We evaluated the mutation status of c-Met in small cell lung cancer (SCLC) and neuroendocrine tumors (NET), for which relatively limited therapeutic targets have been explored.

Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumors

LUCCHI, MARCO;
2013

Abstract

We evaluated the mutation status of c-Met in small cell lung cancer (SCLC) and neuroendocrine tumors (NET), for which relatively limited therapeutic targets have been explored.
Voortman, J; Harada, T; Chang, R. P; Killian, J. K; Suuriniemi, M; Smith, W. I; Meltzer, P. S; Lucchi, Marco; Wang, Y; Giaccone, G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/871031
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact